Alzheimer's Disease Pipeline Highlights - 2018

  • ID: 4516387
  • Report
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The latest report Alzheimer's Disease Pipeline Highlights - 2018, provides most up-to-date information on key pipeline products in the global Alzheimer's Disease market. It covers emerging therapies for Alzheimer's Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Alzheimer's Disease pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Alzheimer's Disease pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Alzheimer's Disease pipeline products by the company.

Short-term Launch Highlights:
Find out which Alzheimer's Disease pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:
  • Alzheimer's Disease phase 3 clinical trial pipeline products
  • Alzheimer's Disease phase 2 clinical trial pipeline products
  • Alzheimer's Disease phase 1 clinical trial pipeline products
  • Alzheimer's Disease preclinical research pipeline products
  • Alzheimer's Disease discovery stage pipeline products
  • Alzheimer's Disease pipeline products short-term launch highlights
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Alzheimer's Disease Pipeline by Stages
2. Alzheimer's Disease Pipeline by Drug Class
3. Alzheimer's Disease Pipeline by Company
4. Alzheimer's Disease Phase 3 Clinical Trial Insights
5. Alzheimer's Disease Phase 2 Clinical Trial Insights
6. Alzheimer's Disease Phase 1 Clinical Trial Insights
7. Alzheimer's Disease Preclinical Research Insights
8. Alzheimer's Disease Discovery Stage Insights
9. Appendix
10. Research Methodology

List of Tables
Table 1: Alzheimer's Disease Phase 3 Clinical Trials, 2018
Table 2: Alzheimer's Disease Phase 2 Clinical Trials, 2018
Table 3: Alzheimer's Disease Phase 1 Clinical Trials, 2018
Table 4: Alzheimer's Disease Preclinical Research, 2018
Table 5: Alzheimer's Disease Discovery Stage, 2018

List of Figures
Figures 1: Alzheimer's Disease Pipeline Molecules by Clinical Trials Stage, 2018
Figure 2: Alzheimer's Disease Pipeline Molecules by Drug Class, 2018
Figure 3: Alzheimer's Disease Pipeline Molecules by Company, 2018
Figure 4: Alzheimer's Disease Phase 3 Clinical Trial Highlights, 2018
Figure 5: Alzheimer's Disease Phase 2 Clinical Trial Highlights, 2018
Figure 6: Alzheimer's Disease Phase 1 Clinical Trial Highlights, 2018
Figure 7: Alzheimer's Disease Preclinical Research Highlights, 2018
Figure 8: Alzheimer's Disease Discovery Stage Highlights, 2018
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll